[1] Aminoff M, Greenberg D, Simon R. Clinical Neurology 9/E, McGraw Hill Professional; 2015.
[2] Lisak R, Truong D, Carroll W, Bhidayasiri R. International Neurology: A Clinical Approach, Blackwell Publishing Ltd, Singapore; 2009.
[3] Christine C, Aminoff M. Clinical differentiation of parkinsonian syndromes: prognostic and therapeutic relevance, Am J Med. 2004; 117 : 412- 19.
[4] U.S. Pharmacopeia, United States Pharmacopeia and National Formulary (USP 37–NF 32), Rockville, MD: US Pharmacopeia, 2014.
[5] Abdel-Ghany M, Hussein L, Ayad M , Youssef M. Investigation of different spectrophotometric and chemometric methods for determination of entacapone, levodopa and carbidopa in ternary mixture. SPECTROCHIM ACTA A. 2017;171 :236-45.
[6] chandra B, Sarada N. A Simple Validated Stability Indicating RP-HPLC Method for the Determination of Three Antiparkinsonism Compounds in Oral Contraceptive Tablet Formulations. Int J Chemtech Res. 2017; 10 :11-15.
[7] Bhatnagar P, Vyas D, Sinha S, Chakrabarti T. Stability indicating HPLC method for simultaneous estimation of entacapone, levodopa and carbidopa in pharmaceutical formulation. J Chromatogr Sep Tech. 2015; 6 :1-6
[8] Madhavi S, Sultana S, Teja U, Nalluri B, DEVELOPMENT AND VALIDATION OF RP-HPLC-PDA METHOD FOR THE SIMULTANEOUS ESTIMATION OF LEVODOPA, CARBIDOPAAND ENTACAPONE IN BULK AND PHARMACEUTICAL DOSAGE FORMS. Indo Am j pharm. 2014; 4 : 22-29.
[9] Krishna V, Krishna K, Babu B, Development and validation of liquid chromatographic method for the simultaneous estimation of Levodopa, Carbidopa and Entacapone in the combined dosage form, J. Pharm. Res. 2014; 8 : 281-288.
[10] Issa Y, Hassoun M, Zayed A, Application of high performance liquid chromatographic method for the determination of levodopa, carbidopa, and entacapone in tablet dosage forms. J Liq Chromatogr Relat Technol. 2011; 34 : 2433-47.
[11] Bugamelli F, Marcheselli C, Barba E, Raggi M. Determination of l-dopa, carbidopa, 3-O-methyldopa and entacapone in human plasma by HPLC-ED, J PHARMACEUT BIOMED. 2011; 54 : 562- 7.
[12] Gandhi D, Mehta P. Simultaneous RP-HPTLC method for determination of levodopa, carbidopa, and entacapone in combined tablet dosage form.JPC-J PLANAR CHROMAT. 2011; 24 :236-241.
[13] Ribeiro R, Gasparetto J, de Oliveira R, de Francisco T, Martins C, Cardoso M, Pontarolo R. Simultaneous determination of levodopa, carbidopa, entacapone, tolcapone, 3-O-methyldopa and dopamine in human plasma by an HPLC-MS/MS method, Bioanalysis2015; 7 :207-220.
[14] Zeid A, Nasr J, Belal F, Kitagawa S, Kaji N, Baba Y, Walash M. Determination of six anti-Parkinson drugs using cyclodextrin-capillary electrophoresis method: application to pharmaceutical dosage forms, RSC Advances. 2016; 6 :17519-30.
[15] I.C.H.H.T. Guideline, Validation of analytical procedures: text and methodology Q2 (R1), International Conference on Harmonization, Geneva, Switzerland, 2005, pp. 11-12.